Variability in non-nucleoside reverse transcriptase and protease inhibitor concentrations among HIV-infected adults in routine clinical practice

José Moltó, Asunción Blanco, Cristina Miranda, José Miranda, Jordi Puig, Marta Valle, Meritxell DelaVarga, Carmina R. Fumaz, Manuel José Barbanoj, Bonaventura Clotet

Research output: Contribution to journalArticleResearchpeer-review

17 Citations (Scopus)

Abstract

Aims: The objective of this study was to assess interindividual variability in trough concentrations of plasma of non-nucleoside reverse transcriptase inhibitors (NNRTI) and protease inhibitors (PI) among HIV-infected adults in a routine outpatient setting. Methods: One hundred and seventeen patients who attended our clinic for routine blood tests, and who were receiving antiretroviral therapy which included NNRTI or PI were studied. Patients were not informed that drug concentrations were going to be measured until blood sampling. The times of the last antiretroviral dose and of blood sampling were recorded. Drug concentrations were considered optimal if they were above the proposed minimum effective value. In addition, efavirenz, nevirapine and atazanavir concentrations were considered potentially toxic if they were >4.0 mg l-1, >6.0 mg l-1 and >0.85 mg l-1, respectively. Results: Overall, interindividual variability of NNRTI and PI concentrations in plasma was approximately 50%, and only 68.4% of the patients had drug concentrations within the proposed therapeutic range. Poor adherence explained only 35% of subtherapeutic drug concentrations. Conclusion: Interindividual variability in trough concentrations of NNRTI and PI among HIV-infected adults is large in routine clinical practice, with drug concentrations being outside the therapeutic window in a significant proportion of patients. These findings provide further evidence that therapeutic drug monitoring may be useful to guide antiretroviral therapy in clinical practice. © 2006 The Authors.
Original languageEnglish
Pages (from-to)560-566
JournalBritish Journal of Clinical Pharmacology
Volume62
DOIs
Publication statusPublished - 1 Nov 2006

Keywords

  • Antiretroviral agents
  • Clinical practice
  • Drug concentrations
  • HIV infection
  • Interindividual variability

Fingerprint Dive into the research topics of 'Variability in non-nucleoside reverse transcriptase and protease inhibitor concentrations among HIV-infected adults in routine clinical practice'. Together they form a unique fingerprint.

  • Cite this